iTAPVR Study - Phase II Randomized Study

Conditions: Advanced Tumors Interventions: Other: Placebo + conventional treatment including radiotherapy; Combination Product: Radiation: Radiation Therapy ；Biological: Personalized tumor peptide vaccine Sponsors: The University of Hong Kong-Shenzhen Hospital Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials